Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Aug 28, 2016, 08:01 ET European Society of Cardiology (ESC) Congress Poster Session Reveals Results From Pre-Clinical Study Using CardioCell's Stem Cells for Chronic Ischemic Cardiomyopathy

EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2016 -- Study sponsor CardioCell LLC, a global biotechnology company that uses allogeneic stem cells for...


Aug 28, 2016, 02:01 ET CardioCell Reports Positive Results From the First Phase IIa Clinical Trial Using IV Administration of Stem Cells for Chronic Heart Failure Indications

 EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2016 -- Study sponsor CardioCell LLC, a global biotechnology company that uses allogeneic stem...


Aug 27, 2016, 09:49 ET À l'occasion du congrès 2016 de l'ESC, Philips présente une suite complète de solutions en cardiologie pour une approche personnalisée de la prévention, du diagnostic et du traitement des maladies cardiovasculaires

- Des logiciels, solutions et services de cardiologie intégrés pour optimiser le parcours de traitement, avec à la clé...


Aug 27, 2016, 09:47 ET Philips muestra su gama completa de soluciones en el ESC Congress 2016

- Philips muestra su gama completa de soluciones de cardiología para prevención personalizada, diagnosis y tratamiento de...


Aug 26, 2016, 18:11 ET Seqirus presenta un análisis de seguridad integrado que refuerza los perfiles de seguridad e inmunogenicidad de su vacuna trivalente contra la gripe estacional con adyuvante MF59® en adultos de 65 años de edad y mayores

 Hoy Seqirus anuncia los resultados de tres análisis de un total de 42 ensayos clínicos que evaluaron la seguridad e inmunogenicidad...


Aug 26, 2016, 12:34 ET SpaceX Dragon Splashes Down with Crucial NASA Research Samples

SpaceX's Dragon cargo spacecraft splashed down in the Pacific Ocean at 11:47 a.m. EDT Friday, Aug. 26, southwest of Baja California with more than...


Aug 26, 2016, 12:02 ET Seqirus presents analysis reinforcing the safety and immunogenicity profiles of its MF59®-adjuvanted seasonal trivalent influenza vaccine in adults 65 years and older

 Seqirus today announced results from three analyses of a total of 42 clinical trials that evaluated the safety and immunogenicity of its...


Aug 25, 2016, 21:17 ET BirchBioMed announces completion of clinical trial for ground-breaking anti-scarring drug

BirchBioMed Inc. is exclusively licenced by the University of British Columbia to develop anti-scarring drugs and autoimmune therapies based on our...


Aug 25, 2016, 12:00 ET Study Shows Protein Complex Essential to Creating Healthy Blood Cells

A group of proteins best known for helping to activate all mammalian genes has been found to play a particularly commanding role in the natural...


Aug 25, 2016, 11:40 ET Children with Food Allergies Predisposed to Asthma, Rhinitis

 Children with a history of food allergy have a high risk of developing asthma and allergic rhinitis during childhood as well. The risk...


Aug 25, 2016, 10:36 ET FDA Approves Minimally Invasive Valve Replacement (TAVR) for New Group of Patients

 A new group of patients suffering from aortic stenosis is now eligible for a minimally invasive aortic valve replacement. The U.S. Food and...


Aug 25, 2016, 09:00 ET Renew Research Center Conducting Study on the Effects of Better Blood Flow

Renew Research, LLC announced that the Renew Research Center is conducting groundbreaking clinical research to see if the FDA-cleared ECP device...


Aug 25, 2016, 09:00 ET PinnacleHealth Implants Aortic Valve to First Patients in United States after FDA Approval for Commercial Use

 Today, PinnacleHealth became the first hospital in the country to implant the EDWARDS INTUITY Elite valve, a rapid deployment device...


Aug 25, 2016, 09:00 ET Boehringer Ingelheim and Duke Clinical Research Institute Expand Collaboration to Create Largest Patient Registry for Idiopathic Pulmonary Fibrosis (IPF)

Boehringer Ingelheim Pharmaceuticals, Inc. and the Duke Clinical Research Institute (DCRI) announced today the expansion of the Idiopathic...


Aug 25, 2016, 08:00 ET Denali Therapeutics Announces First Clinical Trial Application, Key Collaborations And $130M Series B

 Denali Therapeutics Inc. ("Denali") today announced several critical milestones in the company's growth, including its first Clinical Trial...


Aug 25, 2016, 08:00 ET Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

 Armetheon, Inc., a specialty pharmaceutical company developing novel small molecule drugs for cardiovascular diseases, today announced results...


Aug 25, 2016, 07:30 ET Mallinckrodt Receives FDA Fast-Track Designation for Synacthen® Depot IND Application

 Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced the U.S. Food and Drug Administration (FDA)...


Aug 25, 2016, 07:00 ET Pivotal Study Results Published in New England Journal of Medicine (NEJM) Confirm Safety and Efficacy of INSIGHTEC's Exablate Neuro System for the Treatment of Essential Tremor

 INSIGHTEC, the leader in MR-guided Focused Ultrasound (MRgFUS) therapy, today announced that the New England Journal of Medicine (NEJM) has...


Aug 25, 2016, 06:30 ET Mylan and Biocon Announce Regulatory Submission for Proposed Biosimilar Trastuzumab Accepted for Review by European Medicines Agency

Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) announced today that the European Medicines Agency (EMA) has...


Aug 25, 2016, 06:00 ET Egalet Announces Scientific Presentations at PAINWeek 2016 Meeting

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...